Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Cha, Moon Yong ^a   Han, Sun Ho ^a   Son, Sung Min ^a   Hong, Hyun Seok ^b   Choi, Young Ju ^a   Byun, Jayoung ^a   Mook Jung, Inhee ^a  

^a Seoul National University   (South Korea)

^b Medifron DBT Inc   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); CHLORPROMAZINE; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COMPARTMENTALIZATION; CELL DAMAGE; CELL FUNCTION; CELL MEDIATED CYTOTOXICITY; CELL STRUCTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON MICROSCOPY; ENDOCYTOSIS; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; WESTERN BLOTTING; ANIMAL; CELL LINE; DRUG EFFECT; METABOLISM; MITOCHONDRION;

MUS;

AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; CELL LINE; CHLORPROMAZINE; ENDOCYTOSIS; MICE; MITOCHONDRIA; PEPTIDE FRAGMENTS;

EID: 84859709003     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034929     Document Type: Article

References (40)

1. Lin MT, Beal MF, (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443: 787-795.
2. Chacinska A, Koehler CM, Milenkovic D, Lithgow T, Pfanner N, (2009) Importing mitochondrial proteins: machineries and mechanisms. Cell 138: 628-644.
3. Seelert H, Dani DN, Dante S, Hauss T, Krause F, et al. (2009) From protons to OXPHOS supercomplexes and Alzheimer's disease: structure-dynamics-function relationships of energy-transducing membranes. Biochim Biophys Acta 1787: 657-671.
4. Manczak M, Mao P, Calkins MJ, Cornea A, Reddy AP, et al. (2010) Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons. J Alzheimers Dis 20 (Suppl 2): S609-631.
5. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, et al. (2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21: 3017-3023.
6. Calkins MJ, Reddy PH, (2011) Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons. Biochim Biophys Acta 1812: 507-513.
7. Baloyannis SJ, Costa V, Michmizos D, (2004) Mitochondrial alterations in Alzheimer's disease. Am J Alzheimers Dis Other Demen 19: 89-93.
8. Mizuno Y, Ikebe S, Hattori N, Nakagawa-Hattori Y, Mochizuki H, et al. (1995) Role of mitochondria in the etiology and pathogenesis of Parkinson's disease. Biochim Biophys Acta 1271: 265-274.
9. Shigenaga MK, Hagen TM, Ames BN, (1994) Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci U S A 91: 10771-10778.
10. Trimmer PA, Swerdlow RH, Parks JK, Keeney P, Bennett JP Jr, et al. (2000) Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Exp Neurol 162: 37-50.
11. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, et al. (2000) Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156: 15-20.
12. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, et al. (2000) High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20: 4050-4058.
13. Caspersen C, Wang N, Yao J, Sosunov A, Chen X, et al. (2005) Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J 19: 2040-2041.
14. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, et al. (2006) Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15: 1437-1449.
15. Maurer I, Zierz S, Moller HJ, (2000) A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging 21: 455-462.
16. Reddy PH, Manczak M, Mao P, Calkins MJ, Reddy AP, et al. (2010) Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline. J Alzheimers Dis 20 (Suppl 2): S499-512.
17. Baloyannis SJ, (2006) Mitochondrial alterations in Alzheimer's disease. J Alzheimers Dis 9: 119-126.
18. Du H, Guo L, Yan S, Sosunov AA, McKhann GM, et al. (2010) Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc Natl Acad Sci U S A 107: 18670-18675.
19. Askanas V, McFerrin J, Baque S, Alvarez RB, Sarkozi E, et al. (1996) Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. Proc Natl Acad Sci U S A 93: 1314-1319.
20. Anandatheerthavarada HK, Biswas G, Robin MA, Avadhani NG, (2003) Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 161: 41-54.
21. Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK, (2006) Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci 26: 9057-9068.
22. Hatanpaa K, Chandrasekaran K, Brady DR, Rapoport SI, (1998) No association between Alzheimer plaques and decreased levels of cytochrome oxidase subunit mRNA, a marker of neuronal energy metabolism. Brain Res Mol Brain Res 59: 13-21.
23. Corona C, Pensalfini A, Frazzini V, Sensi SL, (2011) New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc. Cell Death Dis 2: e176.
24. Origlia N, Righi M, Capsoni S, Cattaneo A, Fang F, et al. (2008) Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction. J Neurosci 28: 3521-3530.
25. Han SH, Kim YH, Mook-Jung I, (2011) RAGE: the beneficial and deleterious effects by diverse mechanisms of actions. Mol Cells 31: 91-97.
26. Yan SD, Chen X, Fu J, Chen M, Zhu H, et al. (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691.
27. Yan SD, Stern D, Kane MD, Kuo YM, Lampert HC, et al. (1998) RAGE-Abeta interactions in the pathophysiology of Alzheimer's disease. Restor Neurol Neurosci 12: 167-173.
28. Takuma K, Fang F, Zhang W, Yan S, Fukuzaki E, et al. (2009) RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction. Proc Natl Acad Sci U S A 106: 20021-20026.
29. Kupcsik L, (2011) Estimation of cell number based on metabolic activity: the MTT reduction assay. Methods Mol Biol 740: 13-19.
30. Grazette LP, Boecker W, Matsui T, Semigran M, Force TL, et al. (2004) Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes: implications for herceptin-induced cardiomyopathy. J Am Coll Cardiol 44: 2231-2238.
31. Bezprozvanny I, (2009) Amyloid goes global. Sci Signal 2: pe16.
32. LaFerla FM, Green KN, Oddo S, (2007) Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8: 499-509.
33. Small DH, Gasperini R, Vincent AJ, Hung AC, Foa L, (2009) The role of Abeta-induced calcium dysregulation in the pathogenesis of Alzheimer's disease. J Alzheimers Dis 16: 225-233.
34. Wu F, Yao PJ, (2009) Clathrin-mediated endocytosis and Alzheimer's disease: an update. Ageing Res Rev 8: 147-149.
35. Xiao D, Zhang L, (2008) Upregulation of Bax and Bcl-2 following prenatal cocaine exposure induces apoptosis in fetal rat brain. Int J Med Sci 5: 295-302.
36. Haruna Y, Kashihara N, Satoh M, Tomita N, Namikoshi T, et al. (2007) Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proc Natl Acad Sci U S A 104: 2331-2336.
37. Li N, Liu GT, (2010) The novel squamosamide derivative FLZ enhances BDNF/TrkB/CREB signaling and inhibits neuronal apoptosis in APP/PS1 mice. Acta Pharmacol Sin 31: 265-272.
38. Raisova M, Hossini AM, Eberle J, Riebeling C, Wieder T, et al. (2001) The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J Invest Dermatol 117: 333-340.
39. Cho HJ, Son SM, Jin SM, Hong HS, Shin DH, et al. (2009) RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model. FASEB J 23: 2639-2649.
40. Kadowaki H, Nishitoh H, Urano F, Sadamitsu C, Matsuzawa A, et al. (2005) Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ 12: 19-24.